These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 1933900

  • 1. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C, Fuks Z, Drobnjak M, Moreno C, Eisenbach L, Feldman M.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [Abstract] [Full Text] [Related]

  • 2. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T, Ishihara T, Campoli M, Ferrone S.
    Tissue Antigens; 2005 May 01; 65(5):419-28. PubMed ID: 15853896
    [Abstract] [Full Text] [Related]

  • 3. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G, Ebert T, Finstad CL, Sheinfeld J, Gomahr A, Aulitzky W, Bander NH.
    J Urol; 1996 Jan 01; 155(1):361-7. PubMed ID: 7490887
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans.
    Rubin JT, Elwood LJ, Rosenberg SA, Lotze MT.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7086-92. PubMed ID: 2582450
    [Abstract] [Full Text] [Related]

  • 5. Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.
    Hanak L, Slaby O, Lauerova L, Kren L, Nenutil R, Michalek J.
    Med Sci Monit; 2009 Dec 15; 15(12):CR638-43. PubMed ID: 19946235
    [Abstract] [Full Text] [Related]

  • 6. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.
    Sakamoto J, Furukawa K, Cordon-Cardo C, Yin BW, Rettig WJ, Oettgen HF, Old LJ, Lloyd KO.
    Cancer Res; 1986 Mar 15; 46(3):1553-61. PubMed ID: 3510728
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM, Aptsiauri N, Vazquez F, Cozar JM, Canton J, Cabrera T, Tallada M, Garrido F, Ruiz-Cabello F.
    Tissue Antigens; 2006 Oct 15; 68(4):303-10. PubMed ID: 17026465
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma.
    Momburg F, Ziegler A, Harpprecht J, Möller P, Moldenhauer G, Hämmerling GJ.
    J Immunol; 1989 Jan 01; 142(1):352-8. PubMed ID: 2462591
    [Abstract] [Full Text] [Related]

  • 13. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells.
    Pantel K, Schlimok G, Kutter D, Schaller G, Genz T, Wiebecke B, Backmann R, Funke I, Riethmüller G.
    Cancer Res; 1991 Sep 01; 51(17):4712-5. PubMed ID: 1873815
    [Abstract] [Full Text] [Related]

  • 14. The role of surface HLA-A,B,C molecules in tumour immunity.
    Möller P, Hämmerling GJ.
    Cancer Surv; 1992 Sep 01; 13():101-27. PubMed ID: 1423320
    [Abstract] [Full Text] [Related]

  • 15. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S, Wehler T, Schnürer E, Lennerz V, Brenner W, Melchior S, Gröne M, Nonn M, Strand S, Meyer R, Ranieri E, Huber C, Falk CS, Herr W.
    Cancer Res; 2006 Dec 01; 66(23):11447-54. PubMed ID: 17145892
    [Abstract] [Full Text] [Related]

  • 16. Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma.
    Luboldt HJ, Kubens BS, Rübben H, Grosse-Wilde H.
    Cancer Res; 1996 Feb 15; 56(4):826-30. PubMed ID: 8631020
    [Abstract] [Full Text] [Related]

  • 17. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee HG, Kanz L, Brugger W.
    Cancer Res; 1998 Feb 15; 58(4):732-6. PubMed ID: 9485028
    [Abstract] [Full Text] [Related]

  • 18. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M, Castagna M, Squartini F.
    Appl Pathol; 1984 Feb 15; 2(3):117-27. PubMed ID: 6085790
    [Abstract] [Full Text] [Related]

  • 19. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG, Munoz IM, Nooyen Y, Fleuren GJ.
    Gynecol Oncol; 1995 Jun 15; 57(3):366-75. PubMed ID: 7774840
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.